Technology can predict patients at risk for kidney transplant rejection

09/22/2008 | Renal Business Today

Scientists used solid phase assays to determine who among kidney transplant candidates was at high risk for acute organ rejection. The technology is able to accurately determine the specificity and strength of antibodies in a patient with the aid of beads coated with specific HLA antigens.

View Full Article in:

Renal Business Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ